Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence

Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37(3):614–636. https://doi.org/10.1016/0014-4827(65)90211-9 Foreman KJ, Marquez N, Dolgert A et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 392(10159):2052–2090. https://doi.org/10.1016/S0140-6736(18)31694-5 Juliusson G, Antunovic P, Derolf A et al (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 113:4179–4187. https://doi.org/10.1182/blood-2008-07-172007 Hellmich C, Moore JA, Bowles KM, Rushworth SA (2020) Bone marrow senescence and the microenvironment of hematological malignancies. Front Oncol 10(3389):2020–00230. https://doi.org/10.3389/fonc.2020.00230 Miraki-Moud F, Anjos-Afonso F, Hodby KA et al (2013) Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proc Natl Acad Sci USA 110(33):13576–13581. https://doi.org/10.1073/pnas.1301891110 Al-Matary YS, Botezatu L, Opalka B et al (2016) Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a growth factor independence one dependent manner. Haematologica 101:1216–1227. https://doi.org/10.3324/haematol.2016.143180 Piddock RE, Bowles KM, Rushworth SA (2017) The role of PI3K isoforms in regulating bone marrow microenvironment signaling focusing on acute myeloid leukemia and multiple myeloma. Cancers 9:29. https://doi.org/10.3390/cancers9040029 Piddock RE, Marlein CR, Abdul-Aziz A et al (2018) Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC. Int J Hematol Oncol Stem Cell Res 11:66. https://doi.org/10.1186/s13045-018-0614-4 Stanulla M, Schrappe M (2009) Treatment of childhood acute lymphoblastic leukemia. Semin Hematol 46(1):52–63. https://doi.org/10.1053/j.seminhematol.2008.09.007 Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535–1548. https://doi.org/10.1056/NEJMra023001 Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, Ribeiro RC (2008) Childhood cancer epidemiology in low-income countries. Cancer Cancer 112(3):461–472. https://doi.org/10.1002/cncr.23205 Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the US (1992–2004). Cancer 112(2):416–432. https://doi.org/10.1002/cncr.23169 Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL (2005) A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care 14(1):53–62. https://doi.org/10.1111/j.1365-2354.2005.00513.x Spix C, Eletr D, Blettner M, Kaatsch P (2008) Temporal trends in the incidence rate of childhood cancer in Germany 1987–2004. Int J Cancer 122(8):1859–1867. https://doi.org/10.1002/ijc.23281 Swaminathan R, Rama R, Shanta V (2008) Childhood cancers in Chennai, India, 1990–2001: incidence and survival. Int J Cancer 122(11):2607–2611. https://doi.org/10.1002/ijc.23428 Chen Y, Li J, Zhao Z (2021) Redox control in acute lymphoblastic leukemia: from physiology to pathology and therapeutic opportunities. Cells 10(5):1218. https://doi.org/10.3390/cells10051218 Ehrenfeld V, Fulda S (2020) Thioredoxin inhibitor PX-12 induces mitochondria-mediated apoptosis in acute lymphoblastic leukemia cells. BIOL CHEM 401(2):273–283. https://doi.org/10.1515/hsz-2019-0160 Prieto-Bermejo R, Romo-González M, Pérez-Fernández A, Ijurko C, Hernández-Hernández Á (2018) Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side. J Exp Clin Cancer Res 37(1):1–18. https://doi.org/10.1186/s13046-018-0797-0 Demaria M, Ohtani N, Youssef SA et al (2014) An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 31(6):722–733. https://doi.org/10.1016/j.devcel.2014.11.012 Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685–705. https://doi.org/10.1146/annurev-physiol-030212-183653 Childs BG, Baker DJ, Kirkland JL et al (2014) Senescence and apoptosis: dueling or complementary cell fates. EMBO Rep 15:1139–53. https://doi.org/10.15252/embr.201439245 Yosef R, Pilpel N, Tokarsky-Amiel R et al (2016) Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun 7:11190. https://doi.org/10.1038/ncomms11190 Bakar DJ, Wijshake T, Tchkonia T et al (2011) Clearance of p16Ink4a-positive senescent cells delays aging-associated disorders. Nature 479:232–236. https://doi.org/10.1038/nature10600 Burd CE, Sorrentino JA, Clark KS et al (2013) Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 152:340–351. https://doi.org/10.1016/j.cell.2012.12.010 Patil P, Dong Q, Wang D et al (2019) Systemic clearance of p16INK4a-positive senescent cells mitigates age-associated intervertebral disc degeneration. Aging Cell 18(3):e12927. https://doi.org/10.1111/acel.12927 Hellmich C, Moore JA, Bowles KM et al (2020) Bone marrow senescence and the microenvironment of hematological malignancies. Front Oncol. https://doi.org/10.3389/fonc.2020.00230 Doulatov S, Notta F, Laurenti E et al (2012) Hematopoisiesis: a human perspective. Cell Stem Cell 10:120–136. https://doi.org/10.1016/j.stem.2012.01.006 Geiger H, de Haan G, Florian MC (2013) The ageing haematopoietic stem cell compartment. Nat Rev Immunol 13:376–389. https://doi.org/10.1038/nri3433 Delia D, Mizutani S (2017) The DNA damage response pathway in normal hematopoiesis and malignancies. Int J Hematol 106(3):328–334. https://doi.org/10.1007/s12185-017-2300-7 Chambers SM, Shaw CA, Gatza C et al (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5(8):e201. https://doi.org/10.1371/journal.pbio.0050201 Beerman I, Maloney WJ, Weissmann IL et al (2010) Stem cells and the aging hematopoitic system. Curr Opin Immunol 22:500–506. https://doi.org/10.1016/j.coi.2010.06.007 Shafat MS, Gnaneswaran B, Bowles KM et al (2017) The bone marrow microenvironment - home of the leukemic blasts. Blood Rev 31:277–286. https://doi.org/10.1016/j.blre.2017.03.004 Sun Y, Campisi J, Higano C et al (2012) Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 18(9):1359–1368. https://doi.org/10.1038/nm.2890 Grimwade D, Walker H, Harrison G et al (2001) The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98(5):1312–1320. https://doi.org/10.1182/blood.V98.5.1312 Abdul-Aziz AM, Sun Y, Hellmich C et al (2019) Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment. Blood 133:446–456. https://doi.org/10.1182/blood-2018-04-845420 André T, Meuleman N, Stamatopoulos B et al (2013) Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS ONE 8:e59756. https://doi.org/10.1371/journal.pone.0059756 Guo J, Zhao Y, Fei C et al (2018) Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death Dis 9(5):1–15. https://doi.org/10.1038/s41419-018-0545-6 Deininger MW, Tyner JW, Solary E (2017) Turning the tide in myelodysplastic/myeloproliferative neoplasms. Nat Rev Cancer 17(7):425–440. https://doi.org/10.1038/nrc.2017.40 Sánchez-Aguilera A, Arranz L, Martín-Pérez D, García-García A, Stavropoulou V, Kubovcakova L, Isern J, Martín-Salamanca S, Langa X, Skoda RC, Schwaller J (2014) Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis. Cell Stem Cell 15(6):791–804. https://doi.org/10.1016/j.stem.2014.11.002 Ho YH, Méndez-Ferrer S (2020) Microenvironmental contributions to hematopoietic stem cell aging. Haematologica 105(1):38. https://doi.org/10.3324/haematol.2018.211334 Baker DJ, Wijshake T, Tchkonia T et al (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:232–236. https://doi.org/10.1038/nature10600 Baar MP, Brandt RMC, Putavet DA et al (2017) Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and Senescent. Cell 169:132–47.e16. https://doi.org/10.1016/j.cell.2017.02.031 Demaria M, O’Leary MN, Chang J et al (2017) Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov 7:165–176. https://doi.org/10.1158/2159-8290.CD-16-0241 Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013 Ewald JA, Desotelle JA, Wilding G et al (2010) Therapy-induced senescence in cancer. J Natl Cancer Inst 102:1536–1546. https://doi.org/10.1093/jnci/djq364 Kamijo T, Zindy F, Roussel MF et al (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19 ARF. Cell 91(5):649–659. https://doi.org/10.1016/S0092-8674(00)80452-3 Vergel M, Marin JJ, Estevez P et al (2011) Cellular senescence as a target in cancer control. Aging Res. https://doi.org/10.4061/2011/725365 Lodish H, BerK A, Krieger M et al (2008) Title of chapter in sentence style capitalization. In: Hurst M (ed) Molecular cell biology, vol 21, 5th edn. W. H. Freeman, New York, pp 881–890 Rubin H (2009) The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol 20(7):675–681. https://doi.org/10.1038/nbt0702-675 Jaiswal S, Natarajan P, Silver AJ et al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 377:111–121. https://doi.org/10.1056/NEJMoa1701719 Cavanaugh A, Juengst B, Sheridan K et al (2015) Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer. Oncotarget 6(37):39821. https://doi.org/10.18632/oncotarget.5496 Leal J, Ferrer I, Blanco-Aparicio C et al (2008) S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis. Carcinogenesis 29(11):2089–2095. https://doi.org/10.1093/carcin/bgn198 McHugh D, Gil J (2018) Senescence and aging: causes, consequences, and therapeutic avenues. Int J Cell Biol 217(1):65–77. https://doi.org/10.1083/jcb.201708092 Van Deursen JM (2014) The role of senescent cells in ageing. Nature 509(7501):439–446. https://doi.org/10.1038/nature13193 Barnes PJ, Baker J, Donnelly LE (2019) Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med 200(5):556–564. https://doi.org/10.1164/rccm.201810-1975TR Davalos AR, Coppe JP, Campisi J et al (2010) Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 29(2):273–283. https://doi.org/10.1007/s10555-010-9220-9 Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23(16):2919–2933. https://doi.org/10.1038/sj.onc.1207518 Ventura A, Kirsch DG, McLaughlin ME et al (2007) Restoration of p53 function leads to tumour regression in vivo. Nature 445(7128):661–665. https://doi.org/10.1038/nature05541 Xue W, Zender L, Miething C et al (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445(7128):656–660. https://doi.org/10.1038/nature05529 Döhner H, Estey E, Grimwade D et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129:424–447. https://doi.org/10.1182/blood-2016-08-733196 Sanoff HK, Deal AM, Krishnamurthy J et al (2014) Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju057 Schmitt CA, Fridman JS, Yang M et al (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109(3):335–346. https://doi.org/10.1016/S0092-8674(02)00734-1 Schwarze SR, Fu VX, Desotelle JA et al (2005) The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 7(9):816–823. https://doi.org/10.1593/neo.05250 Moiseeva O, Mallette FA, Mukhopadhyay UK et al (2006) DNA damage signaling and p53-dependent senescence after prolonged β-interferon stimulation. Mol Biol Cell 17(4):1583–1592. https://doi.org/10.1091/mbc.e05-09-0858 Shafat MS, Gnaneswaran B, Bowles KM et al (2017) The bone marrow microenvironment–Home of the leukemic blasts. Blood Rev 31(5):277–286. https://doi.org/10.1016/j.blre.2017.03.004 Vergel M, Carnero A (2010) Bypassing cellular senescence by genetic screening tools. Clin Transl Oncol 12(6):410–417. https://doi.org/10.1007/s12094-010-0528-2 He JL, Zhang Y, Mei TT et al (2019) Telomerase-triggered DNAzyme spiders for exponential amplified assay of cancer cells. Biosens Bioelectron 144:111692. https://doi.org/10.1016/j.bios.2019.111692 Liu JY, Souroullas GP, Diekman BO et al (2019) Cells exhibiting strong p16INK4a promoter activation in vivo display features of senescence. Proc Natl Acad Sci USA 116(7):2603–2611. https://doi.org/10.1073/pnas.1818313116 Kawano Y, Moschetta M, Manier S et al (2015) Targeting the bone marrow microenvironment in multiple myeloma. Immunol Rev 263:160–172. https://doi.org/10.1007/978-3-319-40320-5_6 Vulliamy TJ, Marrone A, Knight SW et al (2006) Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 107(7):2680–2685. https://doi.org/10.1182/blood-2005-07-2622 Artandi SE, DePinho RA (2000) Mice without telomerase: what can they teach us about human cancer? Nat Med 6(8):852–855. https://doi.org/10.1038/78595 Souers AJ, Leverson JD, Boghaert ER et al (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19(2):202–208. https://doi.org/10.1038/nm.3048 Xu M, Pirtskhalava T, Farr JN et al (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246–1256. https://doi.org/10.1038/s41591-018-0092-9 Sommer A, Royle NJ (2020) ALT: a multi-faceted phenomenon. Genes 11(2):133. https://doi.org/10.3390/genes11020133 Baker JR, Donnelly LE, Barnes PJ (2020) Senotherapy: a new horizon for COPD therapy. Chest 158(2):562–570. https://doi.org/10.1016/j.chest.2020.01.027 Baker DJ et al (2016) Naturally occurring p16 Ink4a-positive cells shorten healthy lifespan. Nature 530(7589):184–189. https://doi.org/10.1038/nature16932 Wyld L et al (2020) Senescence and cancer: a review of clinical implications of senescence and senotherapies. Cancers 12(8):2134. https://doi.org/10.3390/cancers12082134 Nardella C et al (2011) Pro-senescence therapy for cancer treatment. Nat Rev Cancer 11(7):503–511. https://doi.org/10.1038/nrc3057 Ritschka B et al (2017) The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev 31(2):172–183. https://doi.org/10.1101/gad.290635.116 Childs BG et al (2017) Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov 16(10):718–735. https://doi.org/10.1038/nrd.2017.116 Kaefer A et al (2014) Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia. Cancer Chemother Pharmacol 74(3):593–602. https://doi.org/10.1007/s00280-014-2530-9 Tse C et al (2008) ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 68(9):3421–3428. https://doi.org/10.1158/0008-5472.CAN-07-5836 Dörr JR et al (2013) Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 501(7467):421–425. https://doi.org/10.1038/nature12437 Kirkland JL, Tchkonia T (2017) Cellular senescence: a translational perspective. EBioMedicine 21:21–28. https://doi.org/10.1016/j.ebiom.2017.04.013 Tchkonia T, Kirkland JL (2018) Aging, cell senescence, and chronic disease: emerging therapeutic strategies. JAMA 320(13):1319–1320. https://doi.org/10.1001/jama.2018.12440 Yousefzadeh MJ et al (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18–28. https://doi.org/10.1016/j.ebiom.2018.09.015